INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $423.08 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2023-04-17
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-12-31 was $38.04K, a 91.18% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-09-30 was $75.62K, a 9.49% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-06-30 was $43.57K, a 51.23% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-03-31 was $265.85K, a 197.13% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2022 was $423.08K, a 39.03% decline from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2021 was $693.88K, a 50.88% increase from fiscal 2020.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2020 was $459.89K, a 2199.43% increase from fiscal 2019.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2019 was $20.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month |
|---|---|---|---|---|
| 2022-12-31 | $38.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $113.66K derived: sum of 2 quarters · filed 2023-04-17 | $157.23K derived: sum of 3 quarters · filed 2023-04-17 | $423.08K 10-K · filed 2023-04-17 |
| 2022-09-30 | $75.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $119.19K derived: sum of 2 quarters · filed 2022-11-14 | $385.04K 10-Q · filed 2022-11-14 | $816.56K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $43.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $309.42K 10-Q · filed 2022-08-15 | $740.94K derived: sum of 3 quarters · filed 2022-08-15 | $824.49K derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | $265.85K 10-Q · filed 2022-05-16 | $697.37K derived: sum of 2 quarters · filed 2022-05-16 | $780.92K derived: sum of 3 quarters · filed 2022-05-16 | $870.25K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $431.52K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $515.07K derived: sum of 2 quarters · filed 2022-03-31 | $604.40K derived: sum of 3 quarters · filed 2022-03-31 | $693.88K 10-K · filed 2022-03-31 |
| 2021-09-30 | $83.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $172.88K derived: sum of 2 quarters · filed 2021-11-15 | $262.36K 10-Q · filed 2021-11-15 | $334.07K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $89.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $178.81K 10-Q · filed 2021-08-16 | $250.52K derived: sum of 3 quarters · filed 2021-08-16 | $317.72K derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | $89.47K 10-Q · filed 2021-05-17 | $161.19K derived: sum of 2 quarters · filed 2021-05-17 | $228.39K derived: sum of 3 quarters · filed 2021-05-17 | $283.40K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | $71.71K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $138.92K derived: sum of 2 quarters · filed 2021-03-30 | $193.92K derived: sum of 3 quarters · filed 2021-03-30 | $459.89K 10-K · filed 2021-03-30 |
| 2020-09-30 | $67.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $122.21K derived: sum of 2 quarters · filed 2020-11-16 | $388.17K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $55.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $320.97K 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | $265.96K 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | $20.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |